Yuxian He

Scripps Institution of Oceanography — United States

Immunology and Microbiology · Life Sciences

54h-index17.0kcitations174works2.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(79), HIV/AIDS drug development and treatment(59), SARS-CoV-2 and COVID-19 Research(57), Animal Virus Infections Studies(28), COVID-19 Clinical Research Studies(24)

Publications174 total

Phosphorylation of shiftless is important for inhibiting the programmed −1 ribosomal frameshift
Science Advances·2025Open Access
Safety evaluation of imidacloprid on the predatory mites Proprioseiopsis asetus and Amblyseius swirskii
Systematic and Applied Acarology·2025
Development of Macrocyclic Peptide-Based Proteasome Inhibitors with Enhanced Blood-Brain Barrier Penetration for Treating Brain Neoplasms
Journal of Medicinal Chemistry·2025· 1 cited
An HIV fusion-inhibitory lipopeptide provides robust post-exposure prophylaxis and prevents viral reservoir seeding in macaques
Cell Reports·2025· 1 citedOpen Access
The efficacy and safety of inhaled peptide YKYY017 for COVID-19 patients with mild illness: a phase 2 randomized controlled trial
Nature Communications·2025· 1 citedOpen Access
The effects and mechanisms of stem cells and exosomes on neurological function protection and recovery after ischemic stroke
Neuroprotection/Neuroprotection (Chichester, England. Print)·2025· 2 citedOpen Access
PRMT3 reverses HIV-1 latency by increasing chromatin accessibility to form a TEAD4-P-TEFb-containing transcriptional hub
Nature Communications·2025· 4 citedOpen Access
Structural characterization of HIV fusion inhibitor LP-98: Insights into antiviral and resistance mechanisms
Antiviral Research·2025· 2 cited
Pharmacokinetic and safety evaluation of lipopeptide-based HIV fusion inhibitor Lipovirtide in rats
Antiviral Research·2025· 1 cited
Comprehensive preclinical characterization of IPB29, a pan-coronavirus fusion inhibitor under clinical trials
Antiviral Research·2025· 2 cited
Addition of a short HIV-1 fusion-inhibitory peptide to PRO 140 antibody dramatically increases its antiviral breadth and potency
Journal of Virology·2025· 2 citedOpen Access
Comprehensive Proteomic Profiling of Exfoliation Glaucoma Via Mass Spectrometry Reveals SVEP1 as a Potential Biomarker
Investigative Ophthalmology & Visual Science·2025· 1 citedOpen Access
Development of lipopeptide-based HIV-1/2 fusion inhibitors targeting the gp41 pocket site with a new design strategy
Antiviral Research·2024· 3 cited
Prolonged release and antiviral efficacy of HIV fusion inhibitor LP-98-loaded microspheres in rhesus macaques
Journal of Controlled Release·2024· 3 citedOpen Access
Investigating the uncertain causal link between gut microbiota and glaucoma: A genetic correlation and Mendelian randomisation study
Clinical and Experimental Ophthalmology·2024· 7 cited
Development of potent pan‐coronavirus fusion inhibitors with a new design strategy
MedComm·2024· 10 citedOpen Access
Characterization of novel HIV fusion-inhibitory lipopeptides with the M-T hook structure
Microbes and Infection·2024· 4 cited
Radiofrequency ablation using the ThermoCool SmartTouch Catheter guided by ablation index versus antiarrhythmic drugs in atrial fibrillation treatment in China: a cost-consequence analysis.
PubMed·2024Open Access
Susceptibility and Resistance of SARS-CoV-2 Variants to LCB1 and Its Multivalent Derivatives
Viruses·2023· 2 citedOpen Access
Design of a bifunctional pan-sarbecovirus entry inhibitor targeting the cell receptor and viral fusion protein
Journal of Virology·2023· 1 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Shibo Jiang(32), Yusen Zhou(16), Shuwen Liu(12), Lanying Du(9), Hong Lü(9), Huihui Chong(7), Guangyu Zhao(6), Asim K. Debnath(6), Kwok‐Yung Yuen(4), Linqi Zhang(4), Yuanmei Zhu(4), Bo-Jian Zheng(3), Stefan Pöhlmann(3), Jinkui Niu(3), Qian Zhao(3), Pamela Siddiqui(3), Bo‐Jian Zheng(3), Chris Chan(3), Dong‐Yan Jin(3), Jingjing Li(3)